We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+5.3%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.53B
AUM Growth
+$159M
(+3%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
20.92%
Holding
797
New
64
Increased
251
Reduced
262
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$42M |
| 2 |
CF Industries
CF
|
+$41.4M |
| 3 |
BEAV
B/E Aerospace Inc
BEAV
|
+$36.2M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$33.3M |
| 5 |
Sunoco
SUN
|
+$29.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$55.7M |
| 2 |
ITC
ITC HOLDINGS CORP
ITC
|
+$38.9M |
| 3 |
AGN
Allergan Inc
AGN
|
+$38.3M |
| 4 |
Accenture
ACN
|
+$37.2M |
| 5 |
Tesla
TSLA
|
+$35.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.43% |
| 2 | Financials | 16.55% |
| 3 | Consumer Discretionary | 12.19% |
| 4 | Industrials | 12.01% |
| 5 | Technology | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Qualcomm
QCOM
$176B
| $5.63M | 0.1% |
81,123
-4,718
| -5% | -$332K |
|
127
Costco
COST
$415B
| $5.53M | 0.1% |
36,526
+1,102
| +3% | +$162K |
|
128
Genesis Energy
GEL
$2B
| $5.34M | 0.1% |
113,620
+3,695
| +3% | +$164K |
|
129
Chubb
CB
$131B
| $5.28M | 0.1% |
47,369
-2,372
| -5% | -$267K |
|
130
Illinois Tool Works
ITW
$80.2B
| $5.05M | 0.09% |
52,007
+4,162
| +9% | +$401K |
|
131
Alibaba
BABA
$289B
| $5.03M | 0.09% |
60,478
-391,123
| -87% | -$35.3M |
|
132
McDonald's
MCD
$184B
| $4.95M | 0.09% |
50,793
-5,604
| -10% | -$532K |
|
133
PepsiCo
PEP
$191B
| $4.92M | 0.09% |
51,477
+1,185
| +2% | +$115K |
|
134
Dollar General
DG
$27.8B
| $4.63M | 0.08% |
61,468
-2,815
| -4% | -$199K |
|
135
RTX Corp
RTX
$286B
| $4.59M | 0.08% |
62,238
-1,104
| -2% | -$82.5K |
|
136
State Street SPDR S&P 500 ETF Trust
SPY
$827B
| $4.49M | 0.08% |
21,767
-6,860
| -24% | -$1.42M |
|
137
MarketAxess Holdings
MKTX
$5.72B
| $4.49M | 0.08% |
54,150
+250
| +0.5% | +$19.8K |
|
138
Manhattan Associates
MANH
$13B
| $4.42M | 0.08% |
87,260
-3,580
| -4% | -$173K |
|
139
PPG Industries
PPG
$25.2B
| $4.32M | 0.08% |
38,270
+492
| +1% | +$56.4K |
|
|
NVO
140
Novo Nordisk
NVO
$205B
| $4.29M | 0.08% |
160,526
+31,500
| +24% | +$725K |
|
141
ASML
ASML
$666B
| $4.25M | 0.08% |
42,018
-1,804
| -4% | -$190K |
|
142
Abbott
ABT
$193B
| $4.22M | 0.08% |
91,030
-1,515
| -2% | -$69.6K |
|
|
MDVN
143
DELISTED
MEDIVATION, INC.
MDVN
| $4.17M | 0.08% |
64,640
+25,850
| +67% | +$1.48M |
|
144
IBM
IBM
$225B
| $4.11M | 0.07% |
26,792
-3,772
| -12% | -$572K |
|
|
WES
145
DELISTED
Western Gas Partners Lp
WES
| $4.08M | 0.07% |
62,037
-845
| -1% | -$58.4K |
|
146
iShares MSCI EAFE ETF
EFA
$79.8B
| $4.02M | 0.07% |
62,685
+5,135
| +9% | +$323K |
|
|
TYG
147
Tortoise Energy Infrastructure Corp
TYG
$1.1B
| $3.93M | 0.07% |
23,393
-1,013
| -4% | -$175K |
|
|
TTM
148
DELISTED
Tata Motors Limited
TTM
| $3.91M | 0.07% |
86,709
-17,777
| -17% | -$838K |
|
149
BioMarin Pharmaceuticals
BMRN
$12.6B
| $3.81M | 0.07% |
30,532
+7,310
| +31% | +$775K |
|
150
AerCap
AER
$23.3B
| $3.79M | 0.07% |
86,857
+18,694
| +27% | +$788K |
|
Similar funds
CAM
VKH
DL
RBC
TCM
HCM
AL
AT
Geneva Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Geneva Advisors held 797 positions worth $5.53B, up 3% from $5.37B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geneva Advisors's Q1 2015 filing shows 64 new, 251 increased, 262 reduced and 82 closed positions. Its largest new stake was Ulta Beauty: 303,437 shares worth $45.8M. The largest sale was Johnson & Johnson, an estimated $55.7M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geneva Advisors's largest Q1 2015 buy was Ulta Beauty: 303,437 shares worth $45.8M.
- Geneva Advisors added most to CF Industries in Q1 2015, an estimated $41.4M increase.
- Geneva Advisors's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $55.7M.
- Geneva Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $38.3M.
- Geneva Advisors's ten largest holdings make up 21% of its $5.53B portfolio in Q1 2015.
- Geneva Advisors opened 64 new positions and closed 82 in Q1 2015.
- Geneva Advisors's portfolio value rose 3% quarter-over-quarter to $5.53B.
Based on Geneva Advisors's 13F filing for Q1 2015, filed 5 May 2015.